Policy Benefits to Earned Premiums

More than 80% of premiums earned by US insurers is re-directed to policyholders in the form of claims, interests and dividend with L&H insurers spending more than 100% of earned premiums due to high claims volumes.

Download our report to view a 10-year analysis of 75 leading US insurance companies

Loan to Deposit Ratio (LDR)

In 2022, LDR of prominent US banks dropped to 53%, a recovery from the 20% decline in 2020-21. While larger banks experienced substantial decreases, small and mid-sized banks maintained their position with 9-10% decrease in their loan-to-deposit ratios.

Our report includes a 10-year analysis of over 140 US banks

Q1’2023 Revenue Growth Metrics of Asian Companies

We conducted an analysis of the March quarter revenue growth metrics for over 5000 public companies in India, China, South Korea, Taiwan, Indonesia, and Thailand.

Among these economies, Indian companies emerged as the top performers, while other countries displayed a mixed performance across various sectors.

Return on Research Capital (RoRC) Analysis of Pharma Companies

This analysis explores the relationship between research expenditure and revenue in the pharmaceutical industry, analyzing financial parameters across different company sizes.

Expense Ratio Analysis of Leading US Insurance Companies

Property and Casualty (P&C) insurers have traditionally spent more on customer acquisition and policy servicing than their Life and Health (L&H) counterparts.

Download our report to see how expense ratios have trended over the past 15 years.

Net Leverage Ratio Analysis of Leading US Insurance Companies

Property and Casualty (P&C) insurers have been more stable and efficient than Life and Health (L&H) insurers in terms of claims estimations, even during recessionary periods.

Our report includes a 20-year analysis of the net leverage ratio of leading US insurance companies.

Net Debt to Market Cap Benchmarks for Russell 1000 Companies

As the impact of high interest rates takes hold, we look at the best and worst placed companies within the R1000 index.

Over 55% have a Net Debt/Market Cap of under 25%. Health Care, Technology & Industrials best placed; Utilities, Real Estate & Energy worst.

QoQ Revenue Growth Analysis of S&P 500 Companies

With 496 companies declaring their results for the latest fiscal quarter, revenue growth on a YoY basis currently stands at 5.2%.

Use our analysis to gain valuable insights on growth trends at a sector, industry or company level.

Revenue Seasonality of Russell 1000 Companies

Which is the most important quarter from a sales perspective for different R1000 index companies?

We organized the quarterly revenues of the above companies for the last five years in terms of calendar quarters, and the results provide an interesting perspective at the industry/company level.

2023 Revenue Forecasts for S&P 500 Companies

Analyst revenue forecasts for S&P 500 companies in 2023 suggest 1.8% YoY growth compared with over 11% in the previous year (2022 over 2021).

Find out who the leaders/laggards are at the sector and industry levels through our detailed analysis.

Industry Revenue Growth Benchmarks

We have analyzed four-year revenues of over 5300 public companies in the US to map and rank the fastest growing industries in the US for over 140 industries.

Capital Expenditure of Russell 1000 Companies

Russell 1000 companies spend a trillion dollars annually on capex.

Use our visualization tool to map and analyze the capex spend at the sector, industry, and company levels over the last five years.

Firmographics: US Public Companies

The US has 1620 public companies with annual sales of over $1billion, who accounted for 97% of the total revenues generated by over 5300 listed companies. 

Revenue Per Full-time Employee Metrics

Over 4,400 public companies in the US report their full-time employee data, adding up to a payroll headcount of 42.15 million.

Download our report to understand the revenue per employee metrics in over 140 industries.